Figure 3.
Overall survival among MET‐amplified versus non–MET‐amplified esophagogastric cancer (all patients).

Overall survival among MET‐amplified versus non–MET‐amplified esophagogastric cancer (all patients).

Abbreviations: CI, confidence interval; HR, hazard ratio; MET amp, MET‐amplified; MET non‐amp, non–MET‐amplified.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close